Pertussis is a severe respiratory infection caused by Bordetella pertussis, and in 2008,
pertussis was associated with an estimated 16 million cases and 195,000 deaths globally …

Background Routine use of whole‐cell pertussis (wP) vaccines was suspended in some
countries in the 1970s and 1980s because of concerns about adverse effects. Following this …

Justification There is a need to revise/review recommendations regarding existing vaccines
in view of current developments in vaccinology. Process Advisory Committee on Vaccines …

A comprehensive review of observational pertussis vaccine effectiveness (VE) studies is
needed to update gaps from previous reviews. We conducted a systematic review of VE and …

The need for a systematic approach to research on vaccine effectiveness (VE) is increasing
with growing numbers of vaccines and complexity of immunization programs. The diverse …

Objective Countries routinely offering acellular pertussis vaccine, where long-term protection
is not sustained, have the challenge of selecting an optimal schedule to minimise disease …

Owing to their low reactogenicity, confirmed efficacy and availability in combination
vaccines, acellular pertussis (aP)-inactivated poliovirus (IPV) combined vaccines are now …

Background Recent studies worldwide have reported increasing numbers of adults
diagnosed with Bordetella pertussis despite receiving childhood vaccinations. This study …

Abstract Background. Phase II and III clinical studies were conducted to evaluate
immunogenicity and safety of a novel DTaP-IPV vaccine consisting of Sabin inactivated …

In 2008, the number of pertussis cases increased substantially among Japanese
adolescents, despite high coverage with acellular pertussis vaccine (DTaP). This study …